<!--HTML document created with Certent Disclosure Management 6.3.0.196-->
<!--Created on: 10/11/2016 12:43:09 PM-->
<html>
	<head>
		<title>
			8K 2016-10-07
		</title>
	</head>
	<body><div style="margin-left:18pt;margin-right:36pt;">
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<a name="_GoBack"></a><font style="display: inline;font-family:Tahoma;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Tahoma;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;border-top:2pt double #000000 ;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:3pt 18pt 0pt 21pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">SECURITIES AND EXCHANGE COMMISSION</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Washington, DC 20549</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">FORM 8-K</font>
		</p>
		<p style="margin:0pt 18pt 0pt 22.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 13pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:13.5pt;">CURRENT REPORT</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d) of</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;">The Securities Exchange Act of 1934</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">Date of Report (Date of earliest event reported)</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">October 5</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">, 2016</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 24pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:24pt;">Pulse Biosciences, Inc.</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">(Exact name of registrant as specified in its charter)</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:18pt;">
			<tr>
				<td valign="middle" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font><font style="display: inline;font-family:Tahoma;font-size:5pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Nevada</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">001-37744</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">46-5696597</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:181.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(State or other jurisdiction</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">of incorporation)</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Commission</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">File Number)</font></p>
				</td>
				<td valign="bottom" style="width:07.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:171.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(IRS Employer</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">849 Mitten Road</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Burlingame, California 94010</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Address of principal executive offices, including zip code)</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">(650) 697-3939</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Registrant</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">&#x2019;</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">s telephone number, including area code)</font>
		</p>
		<p style="margin:18pt 18pt 0pt 36pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:7.5pt;">(Former name or former address, if changed since last report)</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 245.4pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):</font>
		</p>
		<p style="margin:4.5pt 18pt 0pt 22.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;font-family:Tahoma;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:18pt;">
			<tr>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:17.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:484.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:17.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:484.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:17.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:484.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:17.70pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#x2610;</font></p>
				</td>
				<td valign="middle" style="width:19.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;font-family:Calibri;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:484.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 4.5pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 5pt">
			<font style="display: inline;font-family:Times New Roman;font-size:5pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;border-bottom:2pt double #000000 ;line-height:100%;font-family:Calibri;font-size: 6pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 10pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;;font-size: 12pt"><font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:12pt 18pt 0pt 72pt;line-height:100%;text-indent: -54pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Calibri Light;color:#2E74B5;font-weight:bold;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:12pt 18pt 0pt 72pt;line-height:100%;text-indent: -54pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Calibri Light;color:#2E74B5;font-weight:bold;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:11pt;">Item 5.02</font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:11pt;;font-size: 11pt;font-family:Calibri Light;text-indent:0pt;margin-left:0pt;padding:0pt 24.3pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:11pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:11pt;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-family:Times New Roman;font-weight:bold;">(e) </font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Times New Roman;font-weight:bold;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;">Compensatory Arrangements of Certain Officers</font></font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:5pt 18pt;text-indent:27pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">Effective September 8th, 2015</font><font style="display: inline;color:#000000;font-size:11pt;">,</font><font style="display: inline;color:#000000;font-size:11pt;"> Pulse Biosciences, Inc. entered into an employment agreement with Darrin R. Uecker to serve as the Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s President and Chief Executive Officer.&nbsp;&nbsp;Provisions of the agreement provided Mr. Uecker the right to receive an option to purchase shares of the Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s Common Stock subsequent to the completion of the then planned initial public offering </font><font style="display: inline;color:#000000;font-size:11pt;">(&#x201C;IPO&#x201D;) </font><font style="display: inline;color:#000000;font-size:11pt;">of the Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s Common Stock such that Mr. Uecker would hold options to purchase shares equal to 3% of the Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s post-IPO fully diluted equity with a</font><font style="display: inline;color:#000000;font-size:11pt;">n exercise </font><font style="display: inline;color:#000000;font-size:11pt;">price equal to $4.00</font><font style="display: inline;color:#000000;font-size:11pt;"> per share</font><font style="display: inline;color:#000000;font-size:11pt;">, the planned IPO price.</font>
		</p>
		<p style="margin:5pt 18pt;text-indent:27pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">Effective October 5, 2016, Mr. Uecker offered, and the Company accepted, to forgo receipt of such grant until such time the Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s shareholders approve a new equity incentive plan</font><font style="display: inline;color:#000000;font-size:11pt;"> or an increase in the number of shares available under the existing plan</font><font style="display: inline;color:#000000;font-size:11pt;">.&nbsp;&nbsp;In exchange for Mr. Uecker forgoing receipt of the post-IPO option grant, the Company agreed to amend Mr. Uecker</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s employment agreement </font><font style="display: inline;color:#000000;font-size:11pt;">(the &#x201C;Amendment&#x201D;) </font><font style="display: inline;color:#000000;font-size:11pt;">so that Mr. Uecker will receive</font><font style="display: inline;color:#000000;font-size:11pt;"> (i)</font><font style="display: inline;color:#000000;font-size:11pt;"> an option grant to purchase </font><font style="display: inline;color:#000000;font-size:11pt;">187,286 </font><font style="display: inline;color:#000000;font-size:11pt;">shares of the Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s Common Stock</font><font style="display: inline;color:#000000;font-size:11pt;">, which is</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">a number of shares </font><font style="display: inline;color:#000000;font-size:11pt;">equal to the number of shares he </font><font style="display: inline;color:#000000;font-size:11pt;">would have been</font><font style="display: inline;color:#000000;font-size:11pt;"> entitled to recei</font><font style="display: inline;color:#000000;font-size:11pt;">ve upon completion of the IPO, and (ii) a </font><font style="display: inline;color:#000000;font-size:11pt;">restricted stock </font><font style="display: inline;color:#000000;font-size:11pt;">grant equal </font><font style="display: inline;color:#000000;font-size:11pt;">in value to</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">(A) the </font><font style="display: inline;color:#000000;font-size:11pt;">difference between</font><font style="display: inline;color:#000000;font-size:11pt;"> the </font><font style="display: inline;color:#000000;font-size:11pt;">exercise</font><font style="display: inline;color:#000000;font-size:11pt;"> price </font><font style="display: inline;color:#000000;font-size:11pt;">previously agreed to </font><font style="display: inline;color:#000000;font-size:11pt;">for the post-IPO opti</font><font style="display: inline;color:#000000;font-size:11pt;">on grant</font><font style="display: inline;color:#000000;font-size:11pt;">, which was $4.00 per share,</font><font style="display: inline;color:#000000;font-size:11pt;"> and the </font><font style="display: inline;color:#000000;font-size:11pt;">exercise</font><font style="display: inline;color:#000000;font-size:11pt;"> price on</font><font style="display: inline;color:#000000;font-size:11pt;"> the date of the deferral grant</font><font style="display: inline;color:#000000;font-size:11pt;">, multiplied by (B) 187,286</font><font style="display: inline;color:#000000;font-size:11pt;">.</font><font style="display: inline;color:#000000;font-size:11pt;"> &nbsp;In the event of a change of control that precedes the </font><font style="display: inline;color:#000000;font-size:11pt;">aforementioned </font><font style="display: inline;color:#000000;font-size:11pt;">option grant while Mr. Uecker is still an employee</font><font style="display: inline;color:#000000;font-size:11pt;"> of the Company, Mr. Uecker would</font><font style="display: inline;color:#000000;font-size:11pt;"> be entitled to receive a cash bonus equal to</font><font style="display: inline;color:#000000;font-size:11pt;"> the </font><font style="display: inline;color:#000000;font-size:11pt;">consideration</font><font style="display: inline;color:#000000;font-size:11pt;"> he would have received as a holder of 187,286 vested options to purchase </font><font style="display: inline;color:#000000;font-size:11pt;">the Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x2019;</font><font style="display: inline;color:#000000;font-size:11pt;">s &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">Common S</font><font style="display: inline;color:#000000;font-size:11pt;">tock at a</font><font style="display: inline;color:#000000;font-size:11pt;">n exercise </font><font style="display: inline;color:#000000;font-size:11pt;">price of $4.00 per share. </font><font style="display: inline;color:#000000;font-size:11pt;">The Compensation Committee and the Board of Directors believe that the amendment to Mr. Uecker&#x2019;s employment agreement does not materially change the value of the compensation originally afforded Mr. Uecker. </font>
		</p>
		<p style="margin:5pt 18pt;text-indent:27pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">The foregoing summary does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the </font><font style="display: inline;color:#000000;font-size:11pt;">A</font><font style="display: inline;color:#000000;font-size:11pt;">mendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt 29.25pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt 29.25pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:18pt;margin-right:36pt;">
		<p style="margin:18pt 18pt 0pt;line-height:100%;font-family:Calibri;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:18pt 18pt 0pt;line-height:100%;font-family:Calibri;;font-size: 11pt"><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:18pt 18pt 0pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;">Item 9.01 Financial Statements and Exhibits</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:23pt;"><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;">(d)</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;">Exhibits</font></font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 7pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:auto;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:03.00%;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:94.00%;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:auto;height:6.00pt;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 2pt">
						<font style="display: inline;font-family:Times New Roman;font-size:2pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="middle" style="width:auto;height:6.00pt;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:auto;height:3.30pt;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">10.1</font></p>
				</td>
				<td valign="bottom" style="width:auto;height:3.30pt;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;height:3.30pt;padding:0pt;">
					<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">Amendment to Employment Agreement by and between Darrin R. Uecker and Pulse Biosciences, Inc. </font><font style="display: inline;font-family:Times New Roman;">dated </font><font style="display: inline;font-family:Times New Roman;">October 5</font><font style="display: inline;font-family:Times New Roman;">, 2016.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:11.25pt 18pt 0pt 29.25pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:18pt;margin-right:36pt;">
		<p style="margin:11.25pt 18pt 0pt 29.25pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:11.25pt 18pt 0pt 29.25pt;line-height:100%;text-align:center;font-family:Calibri;;font-size: 11pt"><font style="display: inline;font-family:Times New Roman;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:11.25pt 18pt 0pt 29.25pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;">SIGNATURE</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;">S</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 9pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:369pt;">
			<tr>
				<td valign="middle" style="width:23.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:164.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:23.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="middle" style="width:164.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="top" style="width:189.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 5.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">Pulse Biosciences, Inc.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:23.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="middle" style="width:165.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:23.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 10pt;line-height:100%;text-indent: -10pt;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">By:</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:164.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">/s/ Brian B. Dow </font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:23.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0.8pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:01.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 7pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:164.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">Brian B. Dow</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-style:italic;">Senior Vice President and</font><font style="display: inline;font-family:Times New Roman;font-style:italic;">&nbsp;</font></p>
					<p style="margin:0pt 1.6pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-style:italic;">Chief Financial </font><font style="display: inline;font-family:Times New Roman;font-style:italic;">Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 18pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Tahoma;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			<font style="display: inline;font-family:Times New Roman;">Date: </font><font style="display: inline;font-family:Times New Roman;">October </font><font style="display: inline;font-family:Times New Roman;">11</font><font style="display: inline;font-family:Times New Roman;">, 2016</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:9pt 18pt 0pt 27pt;line-height:100%;font-family:Calibri;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:18pt;margin-right:36pt;">
		<p style="margin:9pt 18pt 0pt 27pt;text-align:center;font-family:Calibri;line-height:107.92%;font-size: 14pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:9pt 18pt 0pt 27pt;text-align:center;font-family:Calibri;line-height:107.92%;;font-size: 14pt"><font style="display: inline;font-family:Times New Roman;font-size:14pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">EXHIBIT INDEX</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="middle" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 10pt">
						<font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:06.36%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="middle" style="width:81.70%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">&#xFEFF;</font></p>
					<p style="margin:0pt 0pt 0pt 18pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">Exhibit No.</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:78.48%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:auto;height:6.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="middle" style="width:84.84%;height:6.00pt;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">10.1</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:78.48%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;">Amendment to Employment Agreement by and between </font><font style="display: inline;font-family:Times New Roman;">Darrin R. Uecker and Pulse Biosciences, Inc. </font><font style="display: inline;font-family:Times New Roman;">dated </font><font style="display: inline;font-family:Times New Roman;">October 5</font><font style="display: inline;font-family:Times New Roman;">, 2016.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:9pt 18pt 0pt 0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "plse-20161011x8k.htm", "description": "8-K", "secsgml_size_bytes": 52443}]
{"company-data": {"conformed-name": "Pulse Biosciences, Inc.", "cik": "0001625101", "assigned-sic": "3841", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37744", "film-number": "161931069"}, "business-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "90401", "phone": "650-697-3939"}, "mail-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "90401"}, "former-company": {"former-conformed-name": "Electroblate, Inc.", "date-changed": "20141113"}}
8K 2016-10-07
﻿
﻿
﻿
﻿
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
﻿
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
﻿
October 5
, 2016
Pulse Biosciences, Inc.
(Exact name of registrant as specified in its charter)
﻿
﻿
Nevada
001-37744
46-5696597
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
849 Mitten Road
Burlingame, California 94010
(Address of principal executive offices, including zip code)
(650) 697-3939
(Registrant
'
s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
﻿
﻿
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
﻿
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
﻿
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
﻿
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
﻿
﻿
﻿
﻿
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
﻿
(e)
Compensatory Arrangements of Certain Officers
﻿
Effective September 8th, 2015
,
Pulse Biosciences, Inc. entered into an employment agreement with Darrin R. Uecker to serve as the Company
'
s President and Chief Executive Officer.  Provisions of the agreement provided Mr. Uecker the right to receive an option to purchase shares of the Company
'
s Common Stock subsequent to the completion of the then planned initial public offering
("IPO")
of the Company
'
s Common Stock such that Mr. Uecker would hold options to purchase shares equal to 3% of the Company
'
s post-IPO fully diluted equity with a
n exercise
price equal to $4.00
per share
, the planned IPO price.
Effective October 5, 2016, Mr. Uecker offered, and the Company accepted, to forgo receipt of such grant until such time the Company
'
s shareholders approve a new equity incentive plan
or an increase in the number of shares available under the existing plan
.  In exchange for Mr. Uecker forgoing receipt of the post-IPO option grant, the Company agreed to amend Mr. Uecker
'
s employment agreement
(the "Amendment")
so that Mr. Uecker will receive
(i)
an option grant to purchase
187,286
shares of the Company
'
s Common Stock
, which is
a number of shares
equal to the number of shares he
would have been
entitled to recei
ve upon completion of the IPO, and (ii) a
restricted stock
grant equal
in value to
(A) the
difference between
the
exercise
price
previously agreed to
for the post-IPO opti
on grant
, which was $4.00 per share,
and the
exercise
price on
the date of the deferral grant
, multiplied by (B) 187,286
.
In the event of a change of control that precedes the
aforementioned
option grant while Mr. Uecker is still an employee
of the Company, Mr. Uecker would
be entitled to receive a cash bonus equal to
the
consideration
he would have received as a holder of 187,286 vested options to purchase
the Company
'
s
Common S
tock at a
n exercise
price of $4.00 per share.
The Compensation Committee and the Board of Directors believe that the amendment to Mr. Uecker's employment agreement does not materially change the value of the compensation originally afforded Mr. Uecker.
The foregoing summary does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the
A
mendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
﻿
﻿
Item 9.01 Financial Statements and Exhibits
﻿
(d)
Exhibits
﻿
﻿
10.1
Amendment to Employment Agreement by and between Darrin R. Uecker and Pulse Biosciences, Inc.
dated
October 5
, 2016.
﻿
SIGNATURE
S
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
﻿
﻿
Pulse Biosciences, Inc.
﻿
By:
/s/ Brian B. Dow
﻿
Brian B. Dow
Senior Vice President and
Chief Financial
Officer
﻿
Date:
October
11
, 2016
﻿
﻿
﻿
﻿
EXHIBIT INDEX
﻿
﻿
Exhibit No.
Description
﻿
10.1
Amendment to Employment Agreement by and between
Darrin R. Uecker and Pulse Biosciences, Inc.
dated
October 5
, 2016.
﻿